A Phase III, Multicentre, Randomised, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Tozorakimab (MEDI3506) in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen (TILIA)

Objective

Clinical Trial Details>>

Principal Investigator(s)
Anthony Breemo, MD

Clinical Trial Categories

  • COVID-19
  • Adult
  • Infectious Disease
  • Pulmonology
Sponsor(s)
AstraZeneca
Contact
Avera Research Institute at 605-504-3154
or ARI@Avera.org

Location

  • Avera Research Institute — Sioux Falls
    6001 S Sharon Ave
    Sioux Falls, SD 57108
    Main: 605-504-3154